Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg

Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg
B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP……………………135mg
Valproic acid IP…………………………….58mg
(Both together corresponds to sodium valproate IP 150mg)
Excipients………………………………………q.s.
Colour: Erythrosine

B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………….200mg
Valproic acid IP……………………………….87mg
(Both together corresponds to sodium valproate IP 250mg)
Excipients……………………………………..q.s.
Colour: Ponceau 4 R

C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………333mg
Valproic acid IP…………………………145mg
(Both together corresponds to sodium valproate IP 500mg)
Excipients…………………………………..q.s.
Colour: Quinoline yellow SS

D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………..499mg
Valproic acid IP……………………………217mg
(Both together corresponds to sodium valproate IP 750mg)
Excipients………………………………………q.s.
Colour: Lake brilliant blue

THERAPEUTIC INDICATIONS:

Sodium Valproate + Valproic Acid is used in the treatment of epilepsy.

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.

WARNING : NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.

STORAGE & DOSAGE:

Storage: Store below 30 °C.
Protect from Light.
Dosage: As directed by the Physician.

Introduction to Sodium Valproate & Valproic Acid Controlled Release Tablets 333mg+145mg

Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg are a combination of two powerful medications widely used in the treatment of epilepsy, bipolar disorder, and migraine prevention. By enhancing gamma-aminobutyric acid (GABA) activity in the brain, these medications stabilize neural activity and reduce the frequency of seizures or mood swings.

The controlled-release (CR) formulation ensures a sustained release of active ingredients over 12–24 hours, maintaining stable drug levels in the bloodstream and improving patient compliance. With rising prevalence of neurological disorders globally, the demand for reliable, high-quality Sodium Valproate & Valproic Acid tablets is continuously increasing.

Taj Pharma, based in Vapi, Gujarat, India, is a recognized manufacturer, exporter, and supplier of this combination, ensuring international-grade quality, purity, and regulatory compliance for global buyers.

Trusted Manufacturer of Sodium Valproate & Valproic Acid Controlled Release Tablets 333mg+145mg

Taj Pharma Ltd. has established itself as a pioneer in antiepileptic and psychiatric drug manufacturing. The company specializes in producing Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg with consistent efficacy, safety, and bioequivalence.

By using state-of-the-art facilities equipped with automated blending, compression, coating, and packaging lines, Taj Pharma ensures every batch meets WHO-GMP and EU-GMP standards. Advanced quality control labs monitor potency, dissolution, stability, and purity to meet both domestic and international regulations.

The company supplies its products to hospitals, clinics, distributors, and PCD pharma franchise partners with custom packaging options to suit global regulatory requirements.

Therapeutic Overview of Sodium Valproate & Valproic Acid Tablets

Indications:

• Epilepsy: Controls partial and generalized seizures, reducing frequency and severity.

• Bipolar Disorder: Stabilizes mood swings and prevents manic episodes.

• Migraine Prevention: Decreases the frequency of migraine attacks by calming neural hyperactivity.

Mechanism of Action:
Sodium Valproate and Valproic Acid increase GABA levels in the brain, which has an inhibitory effect on neuronal activity. This stabilizes excessive firing of neurons, thereby preventing seizures and mood swings.

Common Side Effects:

• Weight gain

• Sleepiness or fatigue

• Tremors

• Liver injury (rare but serious)

• Dizziness and vertigo

• Paresthesia (tingling or pricking sensation)

• Hypersensitivity reactions

• Anemia (low red blood cell count)

• Deafness (rare)

• Urinary incontinence

• Hyponatremia (decreased sodium levels)

• Pain during periods in women

Taj Pharma ensures that each tablet batch undergoes stringent quality control tests to minimize side effects and maximize patient safety.

Detailed Information for Importers, Exporters & Buyers

Regulatory Documentation Provided

Taj Pharma provides comprehensive documentation to facilitate global trade, including:

• WHO-GMP Certificate

• EU-GMP Certificate

• Certificate of Pharmaceutical Product (COPP)

• Certificate of Analysis (CoA)

• Free Sale Certificate (FSC)

• Stability Data and Batch Records

• CTD Dossier for regulatory submissions

Custom Packaging & Labeling

• Alu-Alu blister packs and HDPE bottles

• Custom packaging with import country labeling

• Multi-language labels (English, Spanish, French, Arabic, etc.)

• Tamper-evident and serialized packaging

Shelf-Life, Storage & Dosage Form

• Dosage Form: Controlled Release Tablet

• Strength: 333mg + 145mg

• Shelf Life: 24–36 months

• Storage: Store below 30°C, protected from light and moisture

Export Certifications

• WHO-GMP certified production facilities

• EU-GMP approved

• ISO 9001:2015 Quality Management

• GLP-compliant laboratories

• CTD and CoA dossiers for international regulatory compliance

Target Countries & Export Markets

Taj Pharma exports Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg to over 80 countries, including:

• Asia: Vietnam, Philippines, Thailand, Sri Lanka, Bangladesh

• Africa: Nigeria, Kenya, Ghana, South Africa, Ethiopia

• Middle East: UAE, Saudi Arabia, Iraq, Yemen, Jordan

• Latin America: Peru, Chile, Bolivia, Guatemala, Honduras

• Europe: Ukraine, Poland, Romania, Czech Republic, Belarus

Why is the Most Trusted Manufacturer & Supplier

1. State-of-the-Art Manufacturing Facilities

Taj Pharma’s manufacturing units in Vapi, Gujarat and Mumbai, Maharashtra are equipped with automated processing lines, clean rooms, and advanced quality testing labs. Every batch of Sodium Valproate & Valproic Acid CR tablets undergoes in-process quality control and post-production testing for purity, potency, and uniformity.

2. Affordable Pricing & Quality Assurance

By vertically integrating raw material sourcing and production, Taj Pharma provides high-quality medications at competitive prices, making it an ideal choice for global distributors, hospitals, and PCD franchise partners.

3. Global Supply Chain & Presence

Taj Pharma’s international logistics network ensures timely delivery, customs clearance support, and regulatory dossier management for importers worldwide.

4. Top 20 Export Countries

Nigeria, Kenya, Ghana, Iraq, UAE, Saudi Arabia, Bangladesh, Sri Lanka, Vietnam, Ukraine, Uzbekistan, Colombia, Peru, Ecuador, Philippines, Tanzania, Myanmar, Cambodia, Jordan, Zambia

Technical Product Specification Table:

Call to Action for Buyers & Distributors

If you are an importer, distributor, or hospital procurement professional looking for a trusted Sodium Valproate & Valproic acid CR tablet manufacturer and supplier in India, Taj Pharma is your ideal partner.

📞 Contact Taj Pharma Ltd.
Email: info@tajpharma.com
Website: www.tajpharma.in
Address: Taj Pharma Ltd., Vapi, Gujarat, India

Taj Pharma provides competitive quotations, regulatory documentation, and customized packaging for international buyers.

Top 20 FAQs 

1. What is the use of this combination tablet?
   Treats epilepsy, bipolar disorder, and migraine prevention.

2. Is Taj Pharma WHO-GMP certified?
   Yes, all production is WHO-GMP and EU-GMP certified.

3. What are the common side effects?
   Weight gain, sleepiness, tremors, liver injury, dizziness, and paresthesia.

4. How should these tablets be stored?
   Below 30°C, away from light and moisture.

5. Can Taj Pharma provide export documentation?
   Yes, including COPP, CoA, CTD dossiers, and FSC.

6. What is the shelf life?
   24–36 months.

7. Can it be used during pregnancy?
   Only under strict medical supervision.

8. Does Taj Pharma offer private labeling?
   Yes, custom branding and packaging is available.

9. What is the recommended dosage?
   As prescribed by a physician.

10. Does it interact with other medications?
    Yes, consult a healthcare professional for drug interactions.

11. Are there PCD franchise opportunities?
    Yes, Taj Pharma offers PAN India franchise partnerships.

12. What is the minimum export order quantity?
    Contact Taj Pharma for specific market requirements.

13. Is it safe for long-term use?
    Yes, with regular monitoring by a physician.

14. How quickly does it act?
    Controlled release formulation ensures steady levels over 12–24 hours.

15. Can it be combined with other antiepileptics?
    Yes, under medical supervision.

16. What packaging options are available?
    Alu-Alu blister packs, HDPE bottles, and bulk packs.

17. Does Taj Pharma export worldwide?
    Yes, to over 80 countries.

18. Which pharmacopoeial standards are followed?
    IP, BP, and USP depending on the export market.

19. Is Taj Pharma a reliable supplier for hospitals?
    Yes, bulk supply with regulatory support is provided.

20. How can international buyers contact Taj Pharma?
    Email info@tajpharma.com or visit www.tajpharma.in